Hung Huynh

5PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 16, 2025
Reactivation of the PI3K/mTOR Signaling Pathway Confers Resistance to the FGFR4 Inhibitor FGF401.

Hung Huynh, Wai Har Ng

|Aug 01, 2021
Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma.

David Wai Meng Tai, Thi Bich Uyen Le, Aldo Prawira

|Jun 22, 2021
Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor.

Aldo Prawira, Thi Bich Uyen Le, Rebecca Zhi Wen Ho

|Nov 12, 2020
Ribociclib enhances infigratinib-induced cancer cell differentiation and delays resistance in FGFR-driven hepatocellular carcinoma.

Aldo Prawira, Thi Bich Uyen Le, Thanh Chung Vu

|Sep 10, 2020
Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts.

Anh Tran, Tong San Koh, Aldo Prawira

Pageof 1

Frequent Collaborators

1 joint publications

Aldo Prawira

1 joint publications

Thi Bich Uyen Le

1 joint publications

Thanh Chung Vu

1 joint publications

Wai Har Ng